Asian Spectator

Men's Weekly

.

Ipsen and Medison Pharma Announce Health Canada Approval of Bylvay™ (odevixibat) for the treatment of pruritus due to Progressive Familial Intrahepatic Cholestasis (PFIC)

  • Written by PR Newswire Asia - Asian Spectator
Ipsen and Medison Pharma Announce Health Canada Approval of Bylvay™ (odevixibat) for the treatment of pruritus due to Progressive Familial Intrahepatic Cholestasis (PFIC)Ipsen and Medison Pharma Announce Health Canada Approval of Bylvay™ (odevixibat) for the treatment of pruritus due to Progressive Familial Intrahepatic Cholestasis (PFIC)

Bylvay (odevixibat) is the first and only oral treatment available in Canada for the treatment of pruritus due to this rare genetic condition

ZUG, Switzerland and PARIS, Nov. 13, 2023 /PRNewswire/ -- Today, Ipsen (Euronext: IPN) (ADR: IPSEY), a global biopharmaceutical company focused on transformative medicines in oncology, rare disease and...

Magazine

Diplomasi mendadak Prabowo jadi mediator AS - Iran: Langkah berani atau cari panggung?

(DPN)● Rencana Prabowo mediasi Amerika-Iran memicu keraguan.● Prabowo seakan ingin berperan seimbang untuk bertahan dari tekanan dari luar dan dalam negeri .● Tanpa daya tawar, media...

Masa depan padel: Antara gengsi atau turun kelas agar tren ini langgeng

● Padel sedang menjadi tren teratas aktivitas kaum urban sejak beberapa tahun terakhir.● Padel sudah menjelma sebagai validasi gaya hidup modern pemainnya.● Tren main padel akan sege...

The world’s largest climate finance deal was built to flounder: why funding fails to reach the front-line

Adopted in December 2015, the Paris Agreement commits countries to keeping global temperature rise below 2°C above pre-industrial levels. All 195 signatories set their own plans to meet this share...